| Date Filed | Type | Description |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/07/2023 |
4
| Chu Yu-Waye (Chief Medical Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 425,000 options to buy
@ $6.77, valued at
$2.9M
|
|
| 01/11/2023 |
4
| Chu Yu-Waye (Chief Medical Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 7,825 shares
@ $5.24, valued at
$41k
|
|
| 04/21/2022 |
4
| Chu Yu-Waye (Chief Medical Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 4,062 shares
@ $35.37, valued at
$143.7k
|
|
| 01/27/2022 |
4
| Chu Yu-Waye (Chief Medical Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 33,302 shares
@ $0
Granted 53,058 options to buy
@ $39.87, valued at
$2.1M
|
|
| 01/13/2022 |
4
| Chu Yu-Waye (Senior VP Clinical Development) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 3,547 shares
@ $48.44, valued at
$171.8k
Sold 418 shares
@ $49.1, valued at
$20.5k
|
|
| 12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2021 |
4
| Chu Yu-Waye (Senior VP Clinical Development) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 60,958 shares
@ $0 |
|
| 04/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |